DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Brown JP, Prince RL, Deal C, Recker RR, Kiel DP, de Gregorio LH, Hadji P, Hofbauer LC, Alvaro-Gracia JM, Wang H, Austin M, Wagman RB, Newmark R, Libanati C, San Martin J, Bone HG.
Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial.
J Bone Miner Res 2009; 24: 153-161
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.